SpaceX Files for Stock Market Debut Ticker SPCX Potential Valuation Could Make Elon Musk a Trillionaire Cramer Comments on Atlassians YouTube Controversy Amid Steep Stock Decline US April Payrolls Surprise to the Upside But Economists Flag Underlying Concerns Microns Milestone Dicks Earnings and Paxtons Primary Victory Lead Morning Market Briefing AMD CEO Projects Unprecedented CPU Demand Surge Spanning Five Years How TikToks Discovery Engine Drives Revenue for Brands Seeking an Edge Beyond Traditional Channels QSI Q1 2026 Earnings NarrowerthanExpected Loss Drives Stock Higher OCFC Q1 2026 Earnings EPS Beat Amid Challenging Environment LUMN Q1 2026 Earnings Significant EPS Miss Reflects Ongoing Transformation Challenges BTDR Q1 2026 Earnings EPS Misses Estimates but Stock Surges 1828 AMPL Q1 2026 Earnings EPS Misses Estimates as Shares Rise Despite Challenging Quarter IRWD Q1 2026 Earnings Slight EPS Miss Offset by Investor Optimism Asure Software ASUR Holds Near Support as Shares Edge Higher Barinthus Biotherapeutics BRNS Edges Higher Small Uptick in LowPriced Stock Uniti Group UNIT Gains 177 Approaches Key Resistance Level Merchants Bancorp Preferred Series C MBINN Edges Higher as Support Holds RMCO Surges 1675 Royalty Management Holding Corporation Shows Renewed Momentum New York Yankees Face Financial Uncertainty as Concerns Over Aaron Judge Grow SILO Q4 2023 Earnings EPS Misses Estimates as Biotech Firm Reports Wider Than Expected Loss Eaton Vance EXG Holds Steady Near 936 as Dividend Yield Attracts Income Seekers Addentax Group Corp Q1 2025 Earnings Net Loss Narrowing as Stock Gains 26 Fortress Biotech Preferred Stock FBIOP Q4 2025 Earnings EPS Misses Estimates by Over 108 CLMB Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction Sabine Royalty Trust SBR Q3 2009 Earnings EPS Misses Estimates Amid Weaker Energy Prices ALHC Q1 2026 Earnings Strong Earnings Beat Signals Operational Progress Under Armour Q1 2026 Earnings A Mixed Quarter with EPS Miss but Stock Gains SION Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues RD Investment